title: Effects of indomethacin on Salmonella typhimurium- and cholera toxin-induced fluid accumulation in the porcine small intestine.
abstract: The effect of the cyclooxygenase and prostaglandin E2 (PGE2) synthesis inhibitor, indomethacin, on the secretory responses induced by Salmonella serotype Typhimurium (ST) and cholera toxin (CT), in the porcine small intestine was investigated. ST (10(10) colony-forming units) and CT (56 micrograms) were instilled in tied-off intestinal loops in young anaesthetized pigs receiving intravenous indomethacin in a total dose of 7.5 mg/kg, or saline. The accumulated fluid in the loops and the luminal content of endogenous secretagogues PGE2 and 5-hydroxytryptamine (5-HT) were measured. ST induced fluid accumulation in the jejunum, whereas CT induced fluid accumulation in the jejunum and ileum. Indomethacin had no effect on the secretory responses. Indomethacin had a significant effect on the luminal content of PGE2 in jejunal ST and CT loops, whereas no effect of indomethacin was observed on the luminal content of 5-HT in ST and CT loops. In ST and CT loops, an increased content of PGE2 and 5-HT compared with test loops infused with Ringer's solution was observed. These results indicate that the porcine jejunal secretory response to ST and CT does not involve prostaglandins although indomethacin has an influence on the luminal release of PGE2 but not of 5-HT.
authors.affiliation: Department of Anatomy and Physiology, Royal Veterinary and Agricultural University, Grønnegårdsvej 7, DK-1870 Frederiksberg C, Denmark.
authors.forename: M A
authors.initials: MA
authors.lastname: Unmack
authors.forename: M B
authors.initials: MB
authors.lastname: Hansen
authors.forename: M L
authors.initials: ML
authors.lastname: Grondahl
authors.forename: J E
authors.initials: JE
authors.lastname: Olsen
authors.forename: P
authors.initials: P
authors.lastname: Christensen
authors.forename: E
authors.initials: E
authors.lastname: Skadhauge
mesh_terms: D000818:Animals; D002772:Cholera Toxin / Q000633:toxicity; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015232:Dinoprostone / Q000378:metabolism; D005260:Female; D007213:Indomethacin / Q000494:pharmacology* / Q000627:therapeutic use; D007421:Intestine, Small / Q000187:drug effects* / Q000378:metabolism / Q000382:microbiology; D012481:Salmonella Infections, Animal / Q000188:drug therapy* / Q000503:physiopathology; D012486:Salmonella typhimurium / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000378:metabolism; D013552:Swine; D013553:Swine Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology
chemical_list: D016861:Cyclooxygenase Inhibitors; D012701:Serotonin; D002772:Cholera Toxin; D015232:Dinoprostone; D007213:Indomethacin